Analyst Ratings February 10, 2026

Canaccord Cuts Pagaya Price Target to $32, Cites Prudent Underwriting Amid Mixed Results

Broker maintains Buy rating as earnings beat contrasts with softer volumes and revenue, prompting other firms to pare targets

By Avery Klein PGY
Canaccord Cuts Pagaya Price Target to $32, Cites Prudent Underwriting Amid Mixed Results
PGY

Canaccord Genuity reduced its 12-month price target for Pagaya Technologies to $32 from $39 while keeping a Buy rating. The company reported modestly lower sequential network volume but year-over-year growth, strong liquidity and improving profitability metrics. Quarterly EPS beat expectations but revenue missed forecasts, and other analysts trimmed targets citing softer volumes and guidance that fell short of market hopes.

Key Points

  • Canaccord Genuity cut its price target on Pagaya Technologies to $32 from $39 while maintaining a Buy rating, highlighting prudent underwriting.
  • Pagaya reported network volume of $2.7 billion - down about 3.5% sequentially but up 4% year-over-year - and has a strong current ratio of 5.11.
  • Financials showed 20% year-over-year revenue growth, a 53% rise in adjusted EBITDA with a 29.3% margin, and positive GAAP net income of roughly $34 million for the quarter.

Canaccord Genuity lowered its price target on Pagaya Technologies to $32.00 from $39.00 and retained a Buy rating on the stock. Shares were trading at $14.19, down from $18.64 at the previous close, and appear undervalued when measured against the company's Fair Value analysis.

In the most recent quarter Pagaya reported network volume of $2.7 billion, a sequential decline of about 3.5% but an increase of roughly 4% compared with the year-ago period. Canaccord characterized the pattern as evidence of "continued prudent underwriting with a focus on steady investor returns." The company also shows a strong liquidity position, with a current ratio of 5.11, indicating liquid assets substantially exceed short-term liabilities.

Operational performance showed notable improvement on several profitability measures. Total revenue rose 20% year-over-year, and adjusted EBITDA increased by 53%, producing an adjusted EBITDA margin of 29.3%. Pagaya reported positive GAAP net income of approximately $34 million for the quarter.

Management provided guidance for Q1 2026 that calls for network volume between $2.5 billion and $2.7 billion, total revenue and other income of $315 million to $335 million, adjusted EBITDA in the range of $80 million to $95 million, and GAAP net income from $15 million to $35 million.

For full-year 2026, Pagaya's guidance projects network volume of $11.25 billion to $13 billion, total revenue and other income of $1.4 billion to $1.575 billion, adjusted EBITDA of $410 million to $460 million, and net income of $100 million to $150 million.


Additional recent company disclosures included fourth-quarter 2025 results in which Pagaya posted earnings per share of $0.80, materially above the consensus forecast of $0.35 - a difference quantified as a 128.57% increase over expectations. Revenue for the quarter, however, missed the projection, registering $334.81 million versus the anticipated $348.75 million.

Analyst reactions to the quarterly results and guidance were mixed but generally more cautious than the earnings beat might suggest. Stephens lowered its price target from $33.00 to $25.00 while maintaining an Overweight rating, citing that volumes and revenues came in below forecasts and that the 2026 guidance fell short of market expectations. Citizens followed with its own reduction, trimming its price target to $22.00 from $35.00 and keeping a Market Outperform rating; the firm pointed to expected slower growth and reduced operating leverage in the year ahead. Together, these moves underscore a degree of analyst caution despite Pagaya's positive EPS print.


The juxtaposition of an earnings outperformance with softer top-line results and more conservative guidance has produced divergent responses among brokers. Canaccord's adjustment to a lower price target while preserving a Buy stance reflects a tempered but constructive view, emphasizing prudent underwriting and improving profitability metrics. By contrast, the reductions from Stephens and Citizens reflect concerns tied to near-term growth and operating leverage.

Investors will likely weigh Pagaya's strong liquidity and expanding margins against the sequential dip in network volume, the revenue shortfall in the quarter, and guidance that some analysts consider conservative. These elements together have contributed to recent share-price volatility and to the reassessment of valuation by several brokerages.

Key data points from the company's disclosures and subsequent analyst moves are presented above. Where figures are reported as approximate, the company provided rounded or approximate values in its disclosures.

Risks

  • Volumes and revenues were below some analysts' forecasts, a factor cited by brokers lowering price targets - this affects investor-facing fintechs and credit-focused platforms.
  • Guidance for 2026 did not meet all market expectations, prompting caution among analysts and potentially impacting market sentiment in the fintech sector.
  • Quarterly revenue missed consensus estimates despite an EPS beat, signaling possible pressure on top-line growth and operating leverage for the company and comparable fintech peers.

More from Analyst Ratings

HSBC Lowers Synopsys Rating to Hold, Flags 2026 as Transition Year Feb 21, 2026 DA Davidson Cuts Uber Price Target Citing Elevated Investment; Buy Rating Intact Feb 20, 2026 Freedom Capital Markets Raises Freeport-McMoRan to Buy, Cites Copper Supply Tightness Feb 20, 2026 BofA Lifts CF Industries Price Target After Strong Q4 EBITDA; Maintains Underperform Rating Feb 20, 2026 Truist Lifts Tandem Diabetes Price Target as Company Shifts Toward Pharmacy Model Feb 20, 2026